Glioma: A Common Type of Brain Tumor That can be Fatal

  • Glioma is a common type of tumor originating in the brain, which is formed in glial cells. Glial cells are cells in the brain, which surround and support neurons in the brain including astrocytes, oligodendrocytes, and ependymal cells.
  • Glioma can affect functioning of the brain and it can be fatal, depending on its location and severity of tumor
  • Glioma is of different types: astrocytomas, brain stem gliomas, ependymomas, mixed gliomas (oligo-astrocytomas), oligodendrogliomas, and optic pathway gliomas
  • Headache; seizures; numbness; weakness in the arms, the face, or the legs; and personality changes are some of the major symptoms observed in patients with glioma
  • Risk factors for the development of glioma range from old age (more common in adults between 45-65 years of age) and radiation exposure to family history of glioma
  • Various diagnostic methods are available for detection of glioma. Depending on severity of the disease, different types of treatments or therapies are suggested to patients

For More Info: https://www.transparencymarketresearch.com/glioma-diagnosis-market.html

Are you a Start-up willing to make it Big in the Business? Grab a https://www.transparencymarketresearch.com/glioma-diagnosis-market.htmln Exclusive PDF Brochure of Glioma Diagnosis Market Report

Key Drivers and Restraints of Global Glioma Diagnosis Market

  • Advancements in brain tumor diagnosis and growing prevalence of brain cancer are some of the major factors fueling the global glioma diagnosis market
  • For instance, as per the American Society of Clinical Oncology (ASCO), around 23,820 adults in the U.S. were diagnosed with primary cancerous tumors of the brain and the spinal cord in 2018. Brain tumors accounted for 85% to 90% of all primary CNS (central nervous system) tumors in the country in the year.
  • Combination of most advanced diagnostic scanning techniques and rising awareness regarding various types of brain tumors are some of the major factors responsible for growth of the global glioma diagnosis market
  • Moreover, growing human exposure to radiations in recent times is leading to high rate of incidence of the brain cancer. This is another factor driving the global glioma diagnosis market.

Request Sample of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=75851

Higher Costs of Diagnosis Hamper Global Market

  • Cost of diagnosis of the brain tumor is very high and it is unaffordable for patients in several developing countries. This high cost can adversely impact the global glioma diagnosis market.
  • Regrowth of tumor after treatment and surgery in several cases and adverse effects of chemotherapy are also projected to hamper the global market for glioma diagnosis during the forecast period

Primary Tumor Type Segment Dominates Global Market

  • Based on tumor type, the global glioma diagnosis market can be bifurcated into primary tumors and secondary tumors
  • The primary tumors segment can be sub-divided into astrocytomas, ependymomas, brain stem gliomas, oligodendrogliomas, mixed gliomas, and others
  • The primary tumors segment dominates the global glioma diagnosis market, as primary tumors are more prevalent across the world

Request for Covid-19 Impact Analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=75851

Low-grade Gliomas a Promising Grade Segment

  • In terms of grade, the global glioma diagnosis market can be segmented into low-grade gliomas, high-grade gliomas, and recurrent high-grade gliomas
  • Low-grade gliomas is expected to be the most lucrative segment in the next few years, due to availability of more treatment options and early detection of tumors of low grade

Looking for Regional Analysis or Competitive Landscape in Glioma Diagnosis Market, Ask for a Customized Report

PET Scan Segment Witnesses Strong Growth

  • In terms of diagnosis test, the global glioma diagnosis market can be classified into neurological exams, computed tomography (CT) scan, magnetic resonance imaging (MRI), positron emission tomography (PET) scan, biopsy, electroencephalography (EEG), and others
  • The MRI segment accounted for a major market share in 2018. The PET scans segment is estimated to expand at a high CAGR during the forecast period, owing to better sensitivity and higher rate of precision offered by MRI for glioma diagnosis

Hospitals & Clinics a Dominant End-user Segment

  • Based on end-user, the global glioma diagnosis market can be segmented into hospitals & clinics, diagnostic imaging centers, cancer research institutes, and others
  • The hospitals & clinics segment dominated the global glioma diagnosis market in 2018, owing to the large number of admissions of cancer patients at hospitals and availability of advanced equipment at hospitals and clinics

Buy Glioma Diagnosis Market Report at - https://www.transparencymarketresearch.com/checkout.php?rep_id=75851&ltype=S

North America to Lead Global Market for Glioma Diagnosis

  • In terms of region, the global glioma diagnosis market can be divided into: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America dominated the global glioma diagnosis market in 2018, due to high prevalence of brain tumor in the region, growing radiation exposure, and availability of advanced diagnostic devices in the region
  • Asia Pacific is likely to be a more promising market for glioma diagnosis in the next few years, due to large geriatric population, the large number of patients with cancer, and rise in awareness regarding diseases and their diagnosis in the region. As per a study published by NCBI in September 2011, the rate of prevalence of primary brain tumors in China was 24.56 per 100,000 people in 2006.

Key Manufacturers Operating in Global Market

Key manufacturers operating in the global glioma diagnosis market are:

  • GE Healthcare
  • Siemens Healthineers
  • Koninklijke Philips N.V.
  • Shimadzu Corporation
  • Hitachi Medical Corporation
  • Fujifilm Holdings Corporation
  • Carestream Health
  • Hologic, Inc.
  • CANON MEDICAL SYSTEMS CORPORATION
  • ESAOTE SPA

Global Glioma Diagnosis Market: Research Scope

Global Glioma Diagnosis Market, by Tumor Type

  • Primary Tumors
    • Astrocytomas
    • Ependymomas
    • Brain Stem Gliomas
    • Oligodendrogliomas
    • Mixed Gliomas
    • Others
  • Secondary Tumors

Global Glioma Diagnosis Market, by Grade

  • Low-grade Gliomas
  • High-grade Gliomas
  • Recurrent High-grade Gliomas

Global Glioma Diagnosis Market, by Diagnosis Test

  • Neurological Exams
  • Computed Tomography (CT) Scan
  • Magnetic Resonance Imaging (MRI)
  • Positron Emission Tomography (PET) Scan
  • Biopsy
  • Electroencephalography (EEG)
  • Others

Global Glioma Diagnosis Market, by End-user

  • Hospitals & clinics
  • Diagnostic Imaging Centers
  • Cancer Research Institutes
  • Others

Global Glioma Diagnosis Market, by Region

  • North America
    • S.
    • Canada
  • Europe
    • Germany
    • K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

This intelligence report by TMR is the outcome of intense study and rigorous assessment of various dynamics shaping the growth of the market. TMR nurtures a close-knit team of analysts, strategists, and industry experts who offer clients tools, methodologies, and frameworks to make smarter decisions. Our objective, insights, and actionable analytics provide CXOs and executives to advance their mission-critical priorities with confidence.

The scrutiny of the various forces impacting the dynamics of the market, and key and associated industries, guides enterprises in understanding various consumer propositions. Our clients leverage these insights and perspectives to enhance customer experience in the fast-paced business environment.

All our insights and perspectives are broadly based on 4 Pillars or Stages: ASBC-S, which offer an elaborate and customizable framework for the success of an organization. The essence and the roles of these in organizational successes are highlighted below:

  • Agenda for CXOs: TMR, through the study, sets the tone for agendas that are pertinent to CEOs, CFOs, CIOs, and other CXO executives of businesses operating in the market. The perspectives help our clients to bridge the gap between agenda and action plan. TMR strives to offer guidance to CXOs to undertake mission-critical activities empowered by various business analysis tools, and boost the performance of the organizations. The perspectives guide you to decide on your own marketing mix that align well with the policies, visions, and mission.
  • Strategic Frameworks: The study offers how organizations are setting both short-term and long-term strategic plans. Our team of experts collaborate and communicate with you to understand these to make your organizations sustainable and resilient during tough times. The insights help them decide sustainable competitive advantage for each business units.
  • Benchmarking for Deciding Target Markets and Brand Positioning: The assessments in the study provides a scrutiny of marketing channels and marketing mix. Our various teams work synergistically with you to help identify your actual and potential direct, indirect, and budget competition areas. Additionally, the study helps you decide most effective budgets for various processes and promotional activities. Furthermore, the study guides you to set benchmarks for integrating people and processes with the 4Ps of marketing. Eventually, this will empower you to find out unique propositioning strategies and niches.
  • Business Composability for Sustainability (C-S): Constant strategy planning for sustainability characterizing our C-S framework in the report has become more relevant than before in the face of disruptions caused by pandemics, recessions, boom and bust cycles, and changing geopolitical scenario. The TMR study offers a high level of customization to help you achieve business composability. Composable enterprises are increasingly gaining the attention of CXOs in order to help them combat market volatility. Our analysts and industry experts help you wade through such uncertainties and guide you to become a smart sustainable business in entirety.

 

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact

Mr. Rohit Bhisey
Transparency Market Research

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/